By Andy Choi
OMNIlife science, an operating division of Orthopaedic Synergy, recently declared that its subsidiary Praxim has achieved two additional patents from the United States Patent and Trademark Office. These patents were based on innovative robotic-assisted surgery products and revolutionary computer platform.
Conferred under the U.S. patent terms, the first patent titled ‘System for determining the position of knee prosthesis’ is related to Praxim’s very own BoneMorphing technology that supports knee replacement surgery. The second patent, titled ‘Guiding device for bone cutting’ recognizes Apex Robotic Technology (A.R.T.) platform.
Based on BoneMorphing, surgeons can intra-operatively construct a 3-D model of the patient’s knee joint, eliminating exposure to radiation involved in CT or MRI and the associated costs. Successful knee replacement surgery entails soft-tissue balancing, highly accurate implant positioning, and sizing. With the help of 3D modeling technology from Praxim, surgeons can have an enhanced visualization and can better perform the specific procedures within the patient’s anatomy. BoneMorphing enables surgeons to devise intra-operative surgical plan on the patient’s soft-tissues and ligament balancing, which is a major mandatory process prior to knee replacement surgery.
For excellent results, BoneMorphing is paired with Apex Robotic Technology(ART). Designed to direct the surgical plan, this ART is a robotic cutting guide known for its precision. ART enhances the surgeon’s potential to perform more accurate and safer bone cuts with minimal intra-operative time and less complexity. Conventional navigated blocked were previously used for this purpose. With fewer instruments involved in this procedure, optimization of logistics in hospitals will be improved and instrument processing costs will considerably be reduced.